Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Why do influenza virus subtypes die out? A hypothesis.

Palese P, Wang TT.

MBio. 2011 Aug 30;2(5). pii: e00150-11. doi: 10.1128/mBio.00150-11. Print 2011. Review.

2.

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.

Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2573-8. doi: 10.1073/pnas.1200039109. Epub 2012 Jan 30.

3.

Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.

Ryder AB, Nachbagauer R, Buonocore L, Palese P, Krammer F, Rose JK.

J Virol. 2015 Dec 16;90(5):2544-50. doi: 10.1128/JVI.02598-15.

4.

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.

Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.

Vaccine. 2011 Aug 11;29(35):5911-8. doi: 10.1016/j.vaccine.2011.06.068. Epub 2011 Jun 30.

PMID:
21723354
5.

Epidemiology of the influenza A virus H5N1 subtype and memory of immunity to the H2N2 subtype.

Terajima M, Babon JA, Ennis FA.

MBio. 2012 Jul 10;3(4). pii: e00138-12. doi: 10.1128/mBio.00138-12. Print 2012. No abstract available.

6.

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.

Desheva YA, Smolonogina TA, Donina SA, Rudenko LG.

BMC Res Notes. 2015 Apr 10;8:136. doi: 10.1186/s13104-015-1086-z.

7.

Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.

Ahmed MS, Jacques LC, Mahallawi W, Ferrara F, Temperton N, Upile N, Vaughan C, Sharma R, Beer H, Hoschler K, McNamara PS, Zhang Q.

Antiviral Res. 2015 Feb;114:106-12. doi: 10.1016/j.antiviral.2014.12.008. Epub 2014 Dec 13.

PMID:
25513756
8.

A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.

Benjamin E, Wang W, McAuliffe JM, Palmer-Hill FJ, Kallewaard NL, Chen Z, Suzich JA, Blair WS, Jin H, Zhu Q.

J Virol. 2014 Jun;88(12):6743-50. doi: 10.1128/JVI.03562-13. Epub 2014 Apr 2.

9.

Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.

Oshansky CM, Wong SS, Jeevan T, Smallwood HS, Webby RJ, Shafir SC, Thomas PG.

MBio. 2014 Dec 9;5(6):e02107. doi: 10.1128/mBio.02107-14.

10.

Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

Altenburg AF, Rimmelzwaan GF, de Vries RD.

Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9. Review.

PMID:
25498210
11.

Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza.

Zarnitsyna VI, Ellebedy AH, Davis C, Jacob J, Ahmed R, Antia R.

Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676). pii: 20140248. doi: 10.1098/rstb.2014.0248.

12.

The pathogenesis of influenza in humans.

Zambon MC.

Rev Med Virol. 2001 Jul-Aug;11(4):227-41. Review.

PMID:
11479929
13.

Influenza virus resistance to human neutralizing antibodies.

Crowe JE Jr.

MBio. 2012 Jul 31;3(4):e00213-12. doi: 10.1128/mBio.00213-12. Print 2012.

14.

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.

Khurana S, Loving CL, Manischewitz J, King LR, Gauger PC, Henningson J, Vincent AL, Golding H.

Sci Transl Med. 2013 Aug 28;5(200):200ra114. doi: 10.1126/scitranslmed.3006366.

15.

Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.

Ding H, Tsai C, Zhou F, Buchy P, Deubel V, Zhou P.

PLoS One. 2011 Mar 25;6(3):e17821. doi: 10.1371/journal.pone.0017821.

16.

[Transmissibility and pathogenicity of influenza viruses].

Horimoto T, Yamada S, Kawaoka Y.

Nihon Rinsho. 2010 Sep;68(9):1616-23. Review. Japanese.

PMID:
20845737
17.

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ.

PLoS One. 2011;6(10):e26335. doi: 10.1371/journal.pone.0026335. Epub 2011 Oct 24.

18.

Hemagglutinin stalk domain from H5N1 strain as a potentially universal antigen.

Uranowska K, Tyborowska J, Jurek A, Szewczyk B, Gromadzka B.

Acta Biochim Pol. 2014;61(3):541-50. Epub 2014 Sep 9.

19.

Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.

Srivastava V, Yang Z, Hung IF, Xu J, Zheng B, Zhang MY.

J Virol. 2013 May;87(10):5831-40. doi: 10.1128/JVI.00273-13. Epub 2013 Mar 13.

20.

Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.

Rodríguez-Alvarez M, Velasco-Velasco AM, Alvarez-Anell NJ, Jiménez-Corona ME, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):687-92. doi: 10.1016/j.arcmed.2009.12.002.

PMID:
20304258

Supplemental Content

Support Center